Traws Pharma, Inc.
corporate_fare Company Profile
Traws Pharma, Inc. (NASDAQ:TRAW) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 33 items for TRAW at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Prospectus Filed for Resale of 35.9 Million Shares, Enabling Massive Dilution
- Traws Pharma Reports Q1 Net Loss, Zero Revenue, and Going Concern Warning Amidst Highly Dilutive Financing
- Traws Pharma Reports Q1 Loss, Confirms $60M Financing Extends Runway to Q1 2027
- Traws Pharma Q1 Revenue Estimate Plunges to $0, Signaling Major Operational Halt
- Traws Pharma Registers Over 35 Million Shares for Resale, Signaling Significant Potential Dilution
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$2.79M
Net Income
$9.17M
Diluted EPS
$0.82
Op. Cash Flow
-$18.18M
Free Cash Flow
-$20.77M
Operating Income
-$17.88M
Cash & Equivalents
$3.82M
Debt / Equity
0.00×
Net Margin
328.7%
Shares Outstanding
9.07M sh
Source: 10-K · filed 2026-04-30 · accession 0001104659-26-053041
show_chartPrice Chart
Loading chart...
feed TRAW - Filings & News (Page 2)
TRAW
May 15, 2026, 5:10 PM EDT
Price at Filing:
$1.82
Real-time Price:
$0.165
Change:
-$1.66 (-91%)
Market Cap:
$2.689M
TRAW
May 15, 2026, 7:10 AM EDT
Price at Filing:
$1.65
Real-time Price:
$0.165
Change:
-$1.48 (-90%)
Market Cap:
$2.689M
TRAW
May 15, 2026, 7:05 AM EDT
Price at Filing:
$1.65
Real-time Price:
$0.165
Change:
-$1.48 (-90%)
Market Cap:
$2.689M
TRAW
May 11, 2026, 7:00 AM EDT
Price at Filing:
$2.17
Real-time Price:
$0.165
Change:
-$2.01 (-92%)
Market Cap:
$2.689M
TRAW
May 08, 2026, 5:03 PM EDT
Price at Filing:
$2.14
Real-time Price:
$0.165
Change:
-$1.98 (-92%)
Market Cap:
$2.689M
TRAW
May 05, 2026, 6:55 PM EDT
Price at Filing:
$1.54
Real-time Price:
$0.165
Change:
-$1.38 (-89%)
Market Cap:
$2.689M
TRAW
Apr 28, 2026, 9:41 PM EDT
Price at Filing:
$1.21
Real-time Price:
$0.165
Change:
-$1.05 (-86%)
Market Cap:
$2.689M
TRAW
Apr 15, 2026, 4:47 PM EDT
Price at Filing:
$1.28
Real-time Price:
$0.165
Change:
-$1.11 (-87%)
Market Cap:
$2.689M
TRAW
Apr 15, 2026, 4:02 PM EDT
Traws Pharma Secures Up To $60M Financing, Reports FY25 Net Income, and Positive COVID-19 Trial Data
Price at Filing:
$1.30
Real-time Price:
$0.165
Change:
-$1.13 (-87%)
Market Cap:
$2.689M
TRAW
Apr 15, 2026, 8:00 AM EDT
Price at Filing:
$1.60
Real-time Price:
$0.165
Change:
-$1.44 (-90%)
Market Cap:
$2.689M
TRAW
Feb 19, 2026, 8:42 AM EST
Price at Filing:
$1.50
Real-time Price:
$0.165
Change:
-$1.33 (-89%)
Market Cap:
$2.689M
TRAW
Jan 26, 2026, 8:30 AM EST
Price at Filing:
$2.44
Real-time Price:
$0.165
Change:
-$2.28 (-93%)
Market Cap:
$2.689M
TRAW
Jan 13, 2026, 7:00 AM EST
Price at Filing:
$1.28
Real-time Price:
$0.165
Change:
-$1.12 (-87%)
Market Cap:
$2.689M